Official Website: https://www.sec.gov/

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Compare To Other Companies

Annual (shares)

Value Reported On Form FY FP Start Date End Date Fiscal Period
5,900,000 2019-09-03 10-K 2019 FY 2016-07-01 2017-06-30 CY2017
10,300,000 2020-08-27 10-K 2020 FY 2017-07-01 2018-06-30 CY2018
6,000,000 2021-08-24 10-K 2021 FY 2018-07-01 2019-06-30 CY2019
37,000,000 2022-08-18 10-K 2022 FY 2019-07-01 2020-06-30 CY2020
6,000,000 2023-08-17 10-K 2023 FY 2020-07-01 2021-06-30 CY2021
7,000,000 2024-08-16 10-K 2024 FY 2021-07-01 2022-06-30 CY2022
1,000,000 2025-04-29 8-K 2022-10-02 2023-09-30 CY2023
2,000,000 2025-04-29 8-K 2023-10-01 2024-09-28 CY2024

Quarterly (shares)

Value Reported On Form FY FP Start Date End Date Fiscal Period
7,600,000 2019-11-07 10-Q 2020 Q1 2018-07-01 2018-09-30 CY2018Q3
7,500,000 2020-02-11 10-Q 2020 Q2 2018-10-01 2018-12-31 CY2018Q4
7,200,000 2020-05-11 10-Q 2020 Q3 2019-01-01 2019-03-31 CY2019Q1
17,300,000 2020-11-06 10-Q 2021 Q1 2019-07-01 2019-09-30 CY2019Q3
23,400,000 2021-02-04 10-Q 2021 Q2 2019-10-01 2019-12-31 CY2019Q4
53,600,000 2021-05-06 10-Q 2021 Q3 2020-01-01 2020-03-31 CY2020Q1
23,000,000 2021-11-04 10-Q 2022 Q1 2020-07-01 2020-09-30 CY2020Q3
0 2022-02-03 10-Q 2022 Q2 2020-10-01 2020-12-31 CY2020Q4
2,000,000 2022-05-04 10-Q 2022 Q3 2021-01-01 2021-03-31 CY2021Q1
2,000,000 2022-11-02 10-Q 2023 Q1 2021-07-01 2021-09-30 CY2021Q3
9,000,000 2023-02-08 10-Q 2023 Q2 2021-10-01 2021-12-31 CY2021Q4
9,000,000 2023-05-03 10-Q 2023 Q3 2022-01-01 2022-03-31 CY2022Q1
9,000,000 2023-11-01 10-Q 2024 Q1 2022-07-01 2022-09-30 CY2022Q3
15,000,000 2024-02-07 10-Q 2024 Q2 2022-10-01 2022-12-31 CY2022Q4
15,000,000 2024-05-01 10-Q 2024 Q3 2023-01-01 2023-03-31 CY2023Q1
27,000,000 2024-11-01 10-Q 2025 Q1 2023-07-01 2023-09-30 CY2023Q3
35,000,000 2025-02-05 10-Q 2025 Q2 2023-10-01 2023-12-31 CY2023Q4
27,000,000 2025-05-01 10-Q 2025 Q3 2024-01-01 2024-03-31 CY2024Q1
19,000,000 2024-11-01 10-Q 2025 Q1 2024-07-01 2024-09-30 CY2024Q3
17,000,000 2025-02-05 10-Q 2025 Q2 2024-10-01 2024-12-31 CY2024Q4
16,000,000 2025-05-01 10-Q 2025 Q3 2025-01-01 2025-03-31 CY2025Q1

All Reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares)

Value Reported On Form FY FP Start Date End Date Fiscal Period
5,900,000 2019-09-03 10-K 2019 FY 2016-07-01 2017-06-30 CY2017
10,300,000 2019-09-03 10-K 2019 FY 2017-07-01 2018-06-30
10,300,000 2020-08-27 10-K 2020 FY 2017-07-01 2018-06-30 CY2018
7,600,000 2019-11-07 10-Q 2020 Q1 2018-07-01 2018-09-30 CY2018Q3
7,500,000 2020-02-11 10-Q 2020 Q2 2018-07-01 2018-12-31
7,500,000 2020-02-11 10-Q 2020 Q2 2018-10-01 2018-12-31 CY2018Q4
7,400,000 2020-05-11 10-Q 2020 Q3 2018-07-01 2019-03-31
7,200,000 2020-05-11 10-Q 2020 Q3 2019-01-01 2019-03-31 CY2019Q1
5,600,000 2019-09-03 10-K 2019 FY 2018-07-01 2019-06-30
5,600,000 2020-08-27 10-K 2020 FY 2018-07-01 2019-06-30
6,000,000 2021-08-24 10-K 2021 FY 2018-07-01 2019-06-30 CY2019
17,300,000 2019-11-07 10-Q 2020 Q1 2019-07-01 2019-09-30
17,300,000 2020-11-06 10-Q 2021 Q1 2019-07-01 2019-09-30 CY2019Q3
20,400,000 2020-02-11 10-Q 2020 Q2 2019-07-01 2019-12-31
20,400,000 2021-02-04 10-Q 2021 Q2 2019-07-01 2019-12-31
23,400,000 2020-02-11 10-Q 2020 Q2 2019-10-01 2019-12-31
23,400,000 2021-02-04 10-Q 2021 Q2 2019-10-01 2019-12-31 CY2019Q4
31,400,000 2020-05-11 10-Q 2020 Q3 2019-07-01 2020-03-31
31,400,000 2021-05-06 10-Q 2021 Q3 2019-07-01 2020-03-31
53,600,000 2020-05-11 10-Q 2020 Q3 2020-01-01 2020-03-31
53,600,000 2021-05-06 10-Q 2021 Q3 2020-01-01 2020-03-31 CY2020Q1
36,900,000 2020-08-27 10-K 2020 FY 2019-07-01 2020-06-30
37,000,000 2021-08-24 10-K 2021 FY 2019-07-01 2020-06-30
37,000,000 2022-08-18 10-K 2022 FY 2019-07-01 2020-06-30 CY2020
22,800,000 2020-11-06 10-Q 2021 Q1 2020-07-01 2020-09-30
23,000,000 2021-11-04 10-Q 2022 Q1 2020-07-01 2020-09-30 CY2020Q3
11,400,000 2021-02-04 10-Q 2021 Q2 2020-07-01 2020-12-31
11,000,000 2022-02-03 10-Q 2022 Q2 2020-07-01 2020-12-31
0 2021-02-04 10-Q 2021 Q2 2020-10-01 2020-12-31
0 2022-02-03 10-Q 2022 Q2 2020-10-01 2020-12-31 CY2020Q4
8,200,000 2021-05-06 10-Q 2021 Q3 2020-07-01 2021-03-31
8,000,000 2022-05-04 10-Q 2022 Q3 2020-07-01 2021-03-31
1,800,000 2021-05-06 10-Q 2021 Q3 2021-01-01 2021-03-31
2,000,000 2022-05-04 10-Q 2022 Q3 2021-01-01 2021-03-31 CY2021Q1
6,000,000 2021-08-24 10-K 2021 FY 2020-07-01 2021-06-30
6,000,000 2022-08-18 10-K 2022 FY 2020-07-01 2021-06-30
6,000,000 2023-08-17 10-K 2023 FY 2020-07-01 2021-06-30 CY2021
2,000,000 2021-11-04 10-Q 2022 Q1 2021-07-01 2021-09-30
2,000,000 2022-11-02 10-Q 2023 Q1 2021-07-01 2021-09-30 CY2021Q3
5,000,000 2022-02-03 10-Q 2022 Q2 2021-07-01 2021-12-31
5,000,000 2023-02-08 10-Q 2023 Q2 2021-07-01 2021-12-31
9,000,000 2022-02-03 10-Q 2022 Q2 2021-10-01 2021-12-31
9,000,000 2023-02-08 10-Q 2023 Q2 2021-10-01 2021-12-31 CY2021Q4
6,000,000 2022-05-04 10-Q 2022 Q3 2021-07-01 2022-03-31
6,000,000 2023-05-03 10-Q 2023 Q3 2021-07-01 2022-03-31
9,000,000 2022-05-04 10-Q 2022 Q3 2022-01-01 2022-03-31
9,000,000 2023-05-03 10-Q 2023 Q3 2022-01-01 2022-03-31 CY2022Q1
7,000,000 2022-08-18 10-K 2022 FY 2021-07-01 2022-06-30
7,000,000 2023-08-17 10-K 2023 FY 2021-07-01 2022-06-30
7,000,000 2024-08-16 10-K 2024 FY 2021-07-01 2022-06-30 CY2022
9,000,000 2022-11-02 10-Q 2023 Q1 2022-07-01 2022-09-30
9,000,000 2023-11-01 10-Q 2024 Q1 2022-07-01 2022-09-30 CY2022Q3
12,000,000 2023-02-08 10-Q 2023 Q2 2022-07-01 2022-12-31
12,000,000 2024-02-07 10-Q 2024 Q2 2022-07-01 2022-12-31
15,000,000 2023-02-08 10-Q 2023 Q2 2022-10-01 2022-12-31
15,000,000 2024-02-07 10-Q 2024 Q2 2022-10-01 2022-12-31 CY2022Q4
13,000,000 2023-05-03 10-Q 2023 Q3 2022-07-01 2023-03-31
13,000,000 2024-05-01 10-Q 2024 Q3 2022-07-01 2023-03-31
15,000,000 2023-05-03 10-Q 2023 Q3 2023-01-01 2023-03-31
15,000,000 2024-05-01 10-Q 2024 Q3 2023-01-01 2023-03-31 CY2023Q1
16,000,000 2023-08-17 10-K 2023 FY 2022-07-01 2023-06-30
16,000,000 2024-08-16 10-K 2024 FY 2022-07-01 2023-06-30
1,000,000 2025-04-29 8-K 2022-10-02 2023-09-30 CY2023
27,000,000 2023-11-01 10-Q 2024 Q1 2023-07-01 2023-09-30
27,000,000 2024-11-01 10-Q 2025 Q1 2023-07-01 2023-09-30 CY2023Q3
31,000,000 2024-02-07 10-Q 2024 Q2 2023-07-01 2023-12-31
31,000,000 2025-02-05 10-Q 2025 Q2 2023-07-01 2023-12-31
35,000,000 2024-02-07 10-Q 2024 Q2 2023-10-01 2023-12-31
35,000,000 2025-02-05 10-Q 2025 Q2 2023-10-01 2023-12-31 CY2023Q4
30,000,000 2024-05-01 10-Q 2024 Q3 2023-07-01 2024-03-31
30,000,000 2025-05-01 10-Q 2025 Q3 2023-07-01 2024-03-31
27,000,000 2024-05-01 10-Q 2024 Q3 2024-01-01 2024-03-31
27,000,000 2025-05-01 10-Q 2025 Q3 2024-01-01 2024-03-31 CY2024Q1
29,000,000 2024-08-16 10-K 2024 FY 2023-07-01 2024-06-30
2,000,000 2025-04-29 8-K 2023-10-01 2024-09-28 CY2024
19,000,000 2024-11-01 10-Q 2025 Q1 2024-07-01 2024-09-30 CY2024Q3
18,000,000 2025-02-05 10-Q 2025 Q2 2024-07-01 2024-12-31
17,000,000 2025-02-05 10-Q 2025 Q2 2024-10-01 2024-12-31 CY2024Q4
17,000,000 2025-05-01 10-Q 2025 Q3 2024-07-01 2025-03-31
16,000,000 2025-05-01 10-Q 2025 Q3 2025-01-01 2025-03-31 CY2025Q1

SEC Filings Explorer

Formalu provides easy access to SEC filings and reporting data

Most Recent Filings

2000 most recent SEC filings for the current official filing date

Aggregated Data

SEC filing data for all companies grouped by time and accounting terms

Formalu's Securities and Exchange Commission Page

SEC forms, contact information and locations